EDN1 and central nervous system cancer: ET-1 participates in the progression of different tumours [67], however, whether the presence of ET-1 in gliomas [11] activates the pathway reported in this study (Figure 8) to promote the growth and progression of these tumours remains to be elucidated and warrant further exploration.